Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded by Jarret Glasscock and a team of expert human genome scientists, Cofactor Genomics aims to close the precision medicine gap with innovative RNA-based diagnostics and predictive immune modeling. The company focuses on building advanced biomarkers to improve patient outcomes, particularly in cancer treatment. Their core mission is to leverage unique RNA data models, constructed from vast datasets, to predict patient responses to immunotherapy and other treatments.
Cofactor Genomics has garnered attention through peer-reviewed validation of its technology by leading diagnostic standards organizations like CAP and AMP. Their work has been published in prestigious journals such as the Journal of Molecular Diagnostics. The company's notable achievements include developing next-generation diagnostic tools that significantly enhance the accuracy of treatment matching for cancer patients, thereby making a substantial impact on the field of precision medicine.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Biomarkers, Diagnostics
Technology
AI, Machine Learning
Tags
Biotech, Healthtech
Model Types
Data Information, Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise, Healthcare
Geographic Exposure
Americas
When was Cofactor Genomics founded?
Cofactor Genomics was founded in 2015.
Where is Cofactor Genomics's headquarters located?
Cofactor Genomics's headquarters is located in St. Louis, OK, US.
When was Cofactor Genomics's last funding round?
Cofactor Genomics's most recent funding round was for $1.2M (USD) in August 2023.
How many employees does Cofactor Genomics have?
Cofactor Genomics has 14 employees as of Feb 5, 2024.
How much has Cofactor Genomics raised to-date?
As of July 05, 2023, Cofactor Genomics has raised a total of $29M (USD) since Aug 2, 2023.
Add Comparison
Total Raised to Date
$29M
USD
Last Update Aug 2, 2023
Last Deal Details
$1.2M
USD
Aug 2, 2023
Series Unknown
Current Employees
14
(over the past year)
Last updated: Feb 5, 2024
Employee Growth Trend
High
Medium
Low
Hover over data points to see confidence level and exact employee count
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts